Is it Time to Characterize COVID-19 mRNA Vaccine as Pharmaceutical Drugs & NOT Vaccines?

“The author’s opinion piece leads to a provocative but important proposal—the COVID-19 mRNA vaccine should be classified as a pharmaceutical drug because of the more “straightforward implications” involving associated “pharmacodynamic, pharmacokinetic, clinical and post-marketing safety assessment actions.”

https://www.trialsitenews.com/a/is-it-time-to-characterize-covid-19-mrna-vaccine-as-pharmaceutical-drugs-not-vaccines-72adb601

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: